News

NEXA ALLERSHIELD JUNIOR

Nasal allergies affect 30% of the South African population with an estimated 40% of sufferers being children.

Allergic rhinitis is one of the most common allergies and whilst not life-threatening, it may affect a child’s quality of life and even capacity to concentrate and learn.

Unfortunately for parents wanting to address the issue, many available treatments such as steroidal and sedating anti-histamines can also hamper a child’s ability to learn in the classroom, as per a study published in the Journal of Allergy and Clinical Immunology.

That is why Pharma Dynamics – a pharmaceutical company that specialises in allergy treatment has launched Nexa AllerShield Junior ™ into the South African market. This innovative non-drowsy powdered nasal spray – a first for South Africa – is clinically proven to reduce symptoms by up to 90% and contains no anti-histamines or steroids.

Nexa AllerShield Junior ™ comes in the form of a nasal spray that contains natural cellulose powder of vegetable origin, called hydroxypropyl methylcellulose (HPMC). When applied to the nasal cavity, the powder forms a gel that creates a barrier to shield the nasal membrane and assists in preventing contact with airborne allergens.

There are no known side-effects associated with this product making it suitable to use for children18 months and older. Not only does this treatment shield the nasal cavity from harmful allergens, the device also reduces the need for rescue medication.

Nexa Allershield Junior ™ is available at leading SA pharmacies and can be applied up to three times daily with up to 200 doses per bottle.

For more information log onto www.nexashield.co.za.

BACK TO NEWS
SEE MORE ARTICLES

Receive monthly health tips, advice and news in your inbox